EUROIMMUN US

What EUROIMMUN US does

EUROIMMUN US, Inc. is a US-based in vitro diagnostics manufacturer and wholly owned subsidiary of Revvity, Inc. (NYSE: RVTY), headquartered at 1 Bloomfield Avenue, Mountain Lakes, New Jersey. The company markets a comprehensive diagnostic test portfolio organized across eight categories: autoimmunity, infection, allergy, endocrinology, bone metabolism, neurodegeneration, therapeutic drug monitoring, and human genetics. Its underlying technology stack spans multiple assay platforms, including indirect immunofluorescence (IFA), ELISA, chemiluminescence immunoassay (ChLIA), immunoblot, microarray, real-time PCR, and radioimmunoassays, anchored by the proprietary BIOCHIP mosaic technology that allows multiple antigens to be applied within a single reaction field for multi-parameter testing. The FDA-cleared/approved portfolio includes the T-SPOT.TB latent tuberculosis assay (now automated on the AP2400 platform) and a recently 510(k)-cleared Total Testosterone / SHBG / Free T menu on ChLIA.

The company operates a tightly integrated automation and software ecosystem alongside its reagent business. Automation instruments include the EUROLabWorkstation IFA (capacity for up to 750 substrate fields and 700+ samples per worklist), the EUROBlot One immunoblot processor, the EUROIMMUN Analyzer I for ELISA, the IDS i20 random-access chemiluminescent analyzer, the EUROPattern Microscope Live for IFA interpretation, and the ProciseDx Analyzer (a trFRET platform for therapeutic drug monitoring of infliximab and adalimumab with results under five minutes). Software solutions include EUROLabOffice 4.0 for LIS interoperability, EUROLineScan for blot evaluation, EURORealTime Analysis, and the AI-powered Pattern IQ educational platform for ANA and ANCA pattern recognition.

EUROIMMUN US generates revenue through direct sale of diagnostic kits and reagents (the dominant stream), capital equipment sales of automation instruments, and technical support and field service contracts. Go-to-market is an enterprise B2B field sales model with dedicated product specialists organized by diagnostic category, supported by a technical support hotline (973-794-4241) and quote-based, multi-year contract pricing. Customer segments include hospital laboratories, reference laboratories (including named enterprise accounts such as LabCorp Dublin), and specialty clinical segments across rheumatology, neurology, infectious disease, and endocrinology. Distribution is augmented by a ProciseDx channel partnership extending commercial reach into Canada and into the therapeutic drug monitoring category.

Name

EUROIMMUN US

Legal name

EUROIMMUN US, Inc.

Website

https://euroimmun.us

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

EUROIMMUN US is an in vitro diagnostics manufacturer and subsidiary of Revvity, Inc. that sells autoimmune, infectious disease, allergy, endocrinology, and therapeutic drug monitoring test kits, automation instruments, and software to clinical laboratories across the United States.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• In vitro diagnostics
• Autoimmune diagnostics
• Clinical laboratory automation
• Immunofluorescence assays
• Diagnostic test kits

Headquarters

HQ city

Mountain Lakes

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Test Kits and Reagents: Sale of in vitro diagnostic test kits across multiple disease areas including autoimmune, infectious disease, allergy, endocrinology, and molecular genetics. Products include assays for detecting antibodies, antigens, and genetic markers.
2. Automation Instruments: Sale and distribution of automated laboratory instruments including EUROLabWorkstation IFA, EUROBlot One, EUROAnalyzer I, and related software solutions for laboratory workflow automation.
3. Technical Support Services: Technical support services including field support, installation, and maintenance for laboratory instruments and automation systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

EUROIMMUN US manufactures and distributes in vitro diagnostic (IVD) test kits, reagents, and automated laboratory instruments for clinical laboratories across disease areas including autoimmunity, infectious disease, allergy, endocrinology, neurodegeneration, bone metabolism, therapeutic drug monitoring, and human genetics. The company sells directly to hospital labs, reference labs, and independent clinical labs through an enterprise field sales force, complemented by automation instruments and LIS-integrated software solutions.

Product overview

EUROIMMUN US is a leading manufacturer of in vitro diagnostic products operating as a subsidiary of Revvity, Inc. The company offers a comprehensive diagnostics portfolio organized across eight main product categories: Autoimmunity, Infection, Allergy, Endocrinology, Bone Metabolism, Neurodegeneration, Therapeutic Drug Monitoring, and Human Genetics. The portfolio spans multiple testing methodologies including IFA, ELISA, ChLIA, Immunoblot, Microarray, Real-time PCR, and Radioimmunoassays. EUROIMMUN US complements its diagnostic products with an extensive automation lineup featuring instruments like the EUROLabWorkstation IFA, EUROBlot One, EUROIMMUN Analyzer I, IDS i20, and Auto-Pure systems for TB testing. Software solutions include EUROLabOffice 4.0, EUROLineScan, EURORealTime Analysis, and the AI-powered Pattern IQ educational platform. The company also provides educational resources through Euroimmun US Academy, offering webinars and training modules for laboratory professionals.

Differentiator

Problem solved

Functional benefit

Brands

• Euroimmun US Academy: Educational platform providing webinars, interviews, articles, and training modules covering clinical diagnostics topics including autoimmune, infection, antigen detection, and molecular genetic testing.
• Cogniscience Blog
• Pattern IQ

Products and services

• Autoimmunity Diagnostics Comprehensive diagnostic tests for autoimmune diseases covering rheumatology, neurology, dermatology, nephrology, gastroenterology, and hepatology conditions. Sold to clinical laboratories and hospital systems.
• Infection Diagnostics Diagnostic tests for infectious diseases including tuberculosis, mycoses, sexually transmitted infections, respiratory pathogens, tick-borne diseases, and emerging diseases. Sold to clinical and reference laboratories.
• Allergy Diagnostics Allergy testing products including anti-CCD absorbent, DPA-Dx, and tests for insect venoms, atopy, food, and inhalation allergens. Sold to clinical laboratories.
• Endocrinology Diagnostics Tests for endocrine disorders including sex hormone disorders, adrenal function, growth disorders, hypertension, and lipometabolic conditions. Sold to clinical laboratories.
• Bone Metabolism Diagnostics Tests for bone health including parathyroid hormone, bone turnover markers, calcitonin, and vitamin D using ELISA and ChLIA methods. Sold to clinical laboratories.
• Neurodegeneration Diagnostics Diagnostics for neurodegenerative diseases including Alzheimer's disease and ALS using biomarkers from CSF and blood. Sold to clinical laboratories and neurology departments.
• Therapeutic Drug Monitoring Tests for monitoring drug levels and anti-drug antibodies in patients undergoing biologic therapy, particularly for inflammatory bowel disease. Sold to clinical laboratories.
• Human Genetics Diagnostics Molecular genetic tests for hereditary conditions including factor V Leiden, HLA testing, lactose intolerance, hemochromatosis, and APOE genotyping. Sold to clinical laboratories.
• Diabetes Diagnostics Tests for type 1 diabetes mellitus including islet cell antibodies, GAD65, IA2, ZnT8, and insulin autoantibodies for diagnosis and risk assessment. Sold to clinical laboratories.
• Thyroid Diseases Diagnostics Tests for autoimmune thyroid diseases including Graves' disease and Hashimoto's thyroiditis with antibodies against TPO, TG, and TSH receptor. Sold to clinical laboratories.
• T-SPOT.TB Test FDA-approved interferon-gamma release assay (IGRA) for detection of latent tuberculosis infection, available with the automated AP2400 system. Sold to clinical and reference laboratories.
• EUROLabWorkstation IFA Full automation system for indirect immunofluorescence testing with capacity for up to 750 substrate fields and more than 700 samples per worklist. Sold to high-throughput clinical laboratories.
• EUROIMMUN Analyzer I Automated ELISA processing system for high-throughput clinical laboratory testing. Sold to clinical laboratories.
• EUROPattern Microscope Live Automated IFA interpretation system with live imaging capabilities for fluorescence pattern recognition. Sold to clinical laboratories.
• EUROBlot One Fully automated immunoblot processing system handling up to 44 strips per run with integrated drying, photography, and evaluation. Sold to clinical laboratories.
• IDS i20 Random access chemiluminescent analyzer for specialty testing in clinical laboratories.
• ProciseDx Analyzer Compact trFRET-based analyzer for therapeutic drug monitoring of infliximab and adalimumab levels with results in less than 5 minutes. Sold to clinical laboratories.
• Auto-Pure 20B Automated magnetic bead cell isolation system for the T-SPOT.TB test with capacity for 1-20 samples using strip-based operation.
• Auto-Pure 24 Automated magnetic separation system for the T-SPOT.TB test with capacity for up to 24 samples per run, compatible with liquid handling platforms.
• EUROLabOffice 4.0 Laboratory management software providing central interface between EUROIMMUN instruments and LIS for maximal automation and minimal manual processes.
• EUROLineScan Automated evaluation software for EUROIMMUN blot strips with electronic archiving and LIS connectivity.
• Pattern IQ

Quantifiable outcome

• Up to 750 substrate fields and 700+ samples processed in single worklist with EUROLabWorkstation IFA
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature7 records

Partnerships

Three partnerships are on record, tiered minor and core.

• ProciseDxminorChannel Partner/ Reseller/ Distributor · 29 April 2024ProciseDx announced distribution agreement with Revvity's EUROIMMUN US for distribution of the ProciseDx platform in the United States and Canada. The ProciseDx Analyzer uses trFRET technology for therapeutic drug monitoring.
• RocheminorStrategic or Co-development Partner · 12 April 2016EUROIMMUN announced option agreement with Roche on Zika virus serology testing. This strategic partnership provided rights for Roche to access EUROIMMUN's Zika virus serology technology.
• Revvity, Inc.coreOthersRevvity is the parent company of EUROIMMUN US. Revvity is a global leader in diagnostics and discovery solutions working together to support healthier lives. The partnership provides EUROIMMUN US with global resources, distribution network, and integration into Revvity's broader diagnostic and research portfolio.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Thermo Fisher Scientific (Diagnostics): Thermo Fisher's diagnostics segment (including the Binding Site specialty immunology business) competes with EUROIMMUN US in autoimmune and specialty protein testing, with substantially larger global reach and instrument portfolio.
• Roche Diagnostics: Roche Diagnostics is a broad IVD incumbent offering immunoassay, clinical chemistry, infectious disease, and autoimmune testing at massive scale, providing direct overlap with EUROIMMUN US's specialty menu plus much broader routine-testing coverage.
• Siemens Healthineers: Siemens Healthineers offers an overlapping IVD portfolio in immunoassay, clinical chemistry, infectious disease, and specialty testing through its Atellica and ADVIA Centaur platforms, competing for the same enterprise lab customers.
• Abbott Diagnostics: Abbott Diagnostics competes with EUROIMMUN US across immunoassay, infectious disease, and endocrinology testing through its Architect and Alinity platforms, serving the same hospital and reference lab customers.

Emerging players

• Hologic: Hologic's diagnostics division competes in molecular and infectious disease IVD, with partial overlap to EUROIMMUN US's infectious disease and human genetics testing menus, particularly for women's health and sexually transmitted infections.
• Bühlmann Diagnostics: Bühlmann Diagnostics is a niche specialty IVD player focused on inflammatory bowel disease, autoimmune, and allergy testing, overlapping a subset of EUROIMMUN US's therapeutic drug monitoring and autoimmune menus with a smaller, more focused offering.

Direct peers

• Bio-Rad Laboratories: Bio-Rad is a direct competitor in clinical immunology and autoimmune diagnostics, with a long-established IFA and ELISA portfolio overlapping EUROIMMUN US's autoimmune and infectious disease test menu, and a similarly broad specialty IVD reagent catalog.
• Werfen (Inova Diagnostics): Werfen's Inova Diagnostics division is one of the closest direct competitors to EUROIMMUN US in autoimmune diagnostics, particularly in IFA, ELISA, and immunoblot assays for rheumatology and autoimmune serology.
• DiaSorin: DiaSorin is a specialty IVD company with a chemiluminescence immunoassay (CLIA) platform directly overlapping EUROIMMUN US's ChLIA-based menus in infectious disease, endocrinology, and bone metabolism.
• QuidelOrtho: QuidelOrtho competes in specialty immunoassay and infectious disease diagnostics (including rapid and ELISA-based tests) and serves similar clinical lab customers as EUROIMMUN US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/euroimmun_us

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUROIMMUN US